<DOC>
	<DOCNO>NCT00656266</DOCNO>
	<brief_summary>The objective study compare effect two liver transplant immunosuppression regimens renal function . Patients receive standard combination prednisone high-dose tacrolimus , drug know nephrotoxicity ( Arm A ) compare patient receive prednisone , low-dose tacrolimus mycophenolate mofetil ( MMF ) ( Arm B ) . MMF immunosuppression agent associate nephrotoxicity . The primary end point study renal function measure glomerular filtration rate ( GFR ) . Thirty pediatric liver transplant recipient randomize two arm 1:1 ratio ( i.e . 15 patient group ) . Secondary end point measure patient graft outcome incidence immunosuppression-related complication , include : neurotoxicity , diabetes mellitus , growth retardation , vomit , diarrhea , gastrointestinal hemorrhage , thrombocytopenia , anemia , leukopenia , acute chronic liver graft rejection , posttransplant lymphoproliferative disease ( PTLD ) , viral infection , fungal infection bacterial infection .</brief_summary>
	<brief_title>Trial Calcineurin Inhibitor-Sparing Immunosuppression Regimen Pediatric Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Endstage liver disease acute fulminant hepatic failure recalcitrant conventional medical surgical therapy . Listed candidate pediatric liver transplantation list United Network Organ Sharing ( UNOS ) . Patients must 18 year age young . History autoimmune disease primary sclerosing cholangitis . History endstage renal disease , dialysis treatment acute renal failure ( include hepatorenal syndrome ) . Patients pretransplant renal insufficiency determine glomerular filtration rate ( GFR ) &lt; 80 mL/min/1.73m2 ( see ) . Patients renal agenesis hypoplasia , polycystic kidney disease , hydroureter see pretransplant renal ultrasound . Patients malignancy previous malignancy . Patients active bacterial , viral , fungal infection . Patients pretransplant diagnosis diabetes mellitus . Patients history previous transplant multiorgan recipient . Patients serological evidence HIV , HBSAg HCV . Patients hereditary syndrome cause genetic deficiency hypoxanthineguanine phosphoribosyltransferase ( HGPRT ) LeschNyhan KelleySeegmiller syndrome . Patients history phenylketonuria . Females pregnant breastfeeding . Sexually active female : ) postmenopausal , b ) surgically sterile , c ) use acceptable method contraception ( oral contraceptive , implanted device , injection , barrier device acceptable ; condom use alone acceptable ) . Patients alcohol abuse , substance abuse smoking within previous 6 month . Patients caretaker patient psychogenic factor preclude therapeutic compliance . Inability reach participate hospital within 2 hour notification . Any condition circumstance make unsafe undergo liver transplant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>renal insufficiency and/or renal failure liver transplantation</keyword>
</DOC>